CERVICAL CANCERPelvic Exenteration and ReconstructionSalom, Emery M. MD; Penalver, Manuel A. MDAuthor Information Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami School of Medicine, Jackson Memorial Hospital/Sylvester Comprehensive Cancer Center, Miami, Florida. Reprint requests: Emery M. Salom, MD, 1611 N.W. 12th Avenue, Holtz Building, Room 3003, Miami, Florida 33136. E-mail: Esalom@med.miami.edu No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this article. Received on May 27, 2003; accepted for publication August 20, 2003. The Cancer Journal: September-October 2003 - Volume 9 - Issue 5 - p 415-424 Buy Abstract For the past six decades, pelvic extenteration has been utilized in the treatment of localized central pelvic recurrences after chemo/radiotherapy. The radicality of the procedure that includes resection of the bladder, vulva/vagina, and rectum, although with curative intent, results in comprehensive changes for the patient. For this reason, all patients should undergo extensive psychosocial counseling to prepare them for the changes in body image and lifestyle. Extirpation of the pelvic viscera has undergone a number of modifications since Brunschwig first described it in 1948 to maximize survivability and minimized anatomical distortion. Most of the advancements have been focused on the reconstructive phase after pelvic exenteration. A few select patients can be free of any external appliances such as a colostomy bag with utilization of a low colorectal anastomosis, and can maintain sexual intimacy with creation of a neovagina. In addition, reconstruction of the pelvic floor with omental flaps, dura mater grafts and myocutaneous flaps have decreased postoperative morbidity. In this article, we provide a review of pelvic exenteration in gynecologic oncology, emphasizing preoperative evaluation, surgical techniques and their postoperative management. © 2003 Lippincott Williams & Wilkins, Inc.